Oncology Business Management | Specialty

Frontline Pertuzumab for Metastatic Breast Cancer

January 22nd 2014

Treating Low-Risk HER2-Positive Breast Cancer

January 22nd 2014

Overview of HER2-Targeted Therapies in Breast Cancer

January 22nd 2014

Spending Bill Passes But Cuts to Biomedical Research Funding Remain

January 20th 2014

Last Wednesday, the House of Representatives voted on the Consolidated Appropriations Act of 2014, with the Senate passing the bill last night.

NewLink Genetics Pursues Dual Cancer Immunotherapy Platforms

January 20th 2014

Harnessing multiple components of the immune system to fight cancer is the focus of NewLink Genetics' clinical pipeline.

New Guides Help Practices Improve EHR Use

January 17th 2014

The Office of the National Coordinator for Health Information Technology has released a set of guides and interactive tools to help medical practices improve their use of electronic health records.

CMS to Disclose How Much It Pays Physicians

January 17th 2014

The Centers for Medicare & Medicaid Services will make public a once previously confidential database of Medicare claims.

Urologists Encouraged to Embrace Risk-Based Budgeting

January 14th 2014

As fee-for-service models dwindle under healthcare reform, new reimbursement models based on risk are emerging.

Survey: ACOs Fall Short When Managing Medication Use

January 10th 2014

A survey of 46 representatives from accountable care organizations (ACOs) indicates that critical gaps remain in the organizations' ability to support, manage, and ensure appropriate medication use.

The Value of Infectious Disease Specialists in Oncology Practices Remains Cloudy

January 9th 2014

Patient care is shifting from inpatient to outpatient settings, especially in oncology.

Dabrafenib/Trametinib Combination Approved for Advanced Melanoma

January 9th 2014

The FDA has granted an accelerated approval to the combination of the MEK inhibitor trametinib and the BRAF inhibitor dabrafenib as a treatment for patients with unresectable or metastatic melanoma that harbors a BRAF V600E or V600K mutation.

Is it Time to Integrate Revenue Cycle Management Systems Into Your Practice?

January 7th 2014

With the October deadline for ICD-10 transition looming, now might be the time to consider integrating current electronic health records systems with clinically-driven revenue cycle management (RCM) software.

FDA Rules Hamper Novel Ovarian Cancer Drugs

January 7th 2014

The FDA's rules for approving new drugs for the treatment of women with ovarian cancer pose frustrating problems for researchers developing novel agents and for clinicians seeking to improve outcomes for their patients

Getting Ready for the ICD-10 Transition

January 7th 2014

The transition to ICD-10 is likely to cost your practice both time and money, making a smooth implementation process all the more important.

Ambit Biosciences Looks to Break Through With TKI Quizartinib

January 6th 2014

San Diego-based Ambit Biosciences is staking its success on the kinome, a set of protein kinases in the genome and an important source for targeted therapies in oncology.

Should Your Practice Join a Provider-Based Research Network: January 2, 2014

January 2nd 2014

Provider-based research networks (PBRNs) make clinical trials available to community-based practices.

Significant Changes to Reimbursement Rates in Breast Cancer for 2014

December 31st 2013

Although the changeover to using ICD-10 billing codes won't be mandatory until October 1, 2014, there are many coding changes to consider starting on January 1. Specifically, the reimbursement rate for some genetic testing and imaging involving breast cancer will see significant changes.

What to Do About Long-term Follow-up Care Among Cancer Survivors

December 30th 2013

As new cancer therapies have prolonged life, an interesting question has arisen among community oncologists: "Is it better to transfer long-term cancer survivors to general practitioners or develop clinics for long-term survivors within cancer centers?"

Medicaid Expansion Plans Provide Novel Approaches for Healthcare Coverage

December 23rd 2013

The US Supreme Court's decision to uphold the Affordable Care Act but allow states to decide whether to expand Medicaid has raised a question in many states: Where political leaders have been opposed or split on President Obama's healthcare reforms, is it smart or foolish to cover more people?

First-Year Savings of an Oncology Accountable Care Organization

December 23rd 2013

The first oncology-specific accountable care organization (ACO) reported more than a 2% savings in its first year of existence.